Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Karolin Kleemann"'
Autor:
Saeideh Nakhaei-Rad, Fereshteh Haghighi, Farhad Bazgir, Julia Dahlmann, Alexandra Viktoria Busley, Marcel Buchholzer, Karolin Kleemann, Anne Schänzer, Andrea Borchardt, Andreas Hahn, Sebastian Kötter, Denny Schanze, Ruchika Anand, Florian Funk, Annette Vera Kronenbitter, Jürgen Scheller, Roland P. Piekorz, Andreas S. Reichert, Marianne Volleth, Matthew J. Wolf, Ion Cristian Cirstea, Bruce D. Gelb, Marco Tartaglia, Joachim P. Schmitt, Martina Krüger, Ingo Kutschka, Lukas Cyganek, Martin Zenker, George Kensah, Mohammad R. Ahmadian
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-18 (2023)
Abstract Noonan syndrome (NS), the most common among RASopathies, is caused by germline variants in genes encoding components of the RAS-MAPK pathway. Distinct variants, including the recurrent Ser257Leu substitution in RAF1, are associated with seve
Externí odkaz:
https://doaj.org/article/334fbffc3d50486090984e565b31f40f
Autor:
Iris F. Macheleidt, Priya S. Dalvi, So‐Young Lim, Sonja Meemboor, Lydia Meder, Olivia Käsgen, Marion Müller, Karolin Kleemann, Lingyu Wang, Peter Nürnberg, Vanessa Rüsseler, Stephan C. Schäfer, Esther Mahabir, Reinhard Büttner, Margarete Odenthal
Publikováno v:
Molecular Oncology, Vol 12, Iss 11, Pp 1965-1979 (2018)
Lung adenocarcinoma (LUAD) is the most prevalent subtype of non‐small cell lung cancer. Despite the development of novel targeted and immune therapies, the 5‐year survival rate is still only 21%, indicating the need for more efficient treatment r
Externí odkaz:
https://doaj.org/article/01479b8ac03b4b2698e864566fcccc7f
Autor:
Karolin Kleemann, Jan Patrick Pietras, Michael Hofbeck, Ingo Kutschka, Martin Zenker, George Kensah
Publikováno v:
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie.
Autor:
Vanessa Rüsseler, Karolin Kleemann, Esther Mahabir, Lingyu Wang, Sonja Meemboor, Marion Müller, Olivia Käsgen, Reinhard Büttner, Lydia Meder, Iris Macheleidt, Margarete Odenthal, Peter Nürnberg, Stephan C. Schäfer, Priya Dalvi, Soyoung Lim
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 12, Iss 11, Pp 1965-1979 (2018)
Molecular Oncology, Vol 12, Iss 11, Pp 1965-1979 (2018)
Lung adenocarcinoma (LUAD) is the most prevalent subtype of non‐small cell lung cancer. Despite the development of novel targeted and immune therapies, the 5‐year survival rate is still only 21%, indicating the need for more efficient treatment r